Types of Treatment - Recovery Support Navigator - Addiction
page-template,page-template-full_width,page-template-full_width-php,page,page-id-17053,page-child,parent-pageid-16607,ajax_fade,page_not_loaded,,vss_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive

Types of Treatment

Types of Treatment for Addiction & Substance Abuse

Monroe County Treatment Providers
rehab center, addiction treatment center, recovery treatment center,

Inpatient Withdrawal Management

Patients who are temporarily incapacitated from alcohol or other substances are assisted managing their withdrawal symptoms within a medically structured setting.

Average Length of Stay: 3-7 days, depending on the patient’s individualized needs

Community Residences

Patients live in a supervised, structured living environment with other individuals seeking an alcohol and drug free lifestyle. Each patient receives individualized care based on his or her needs, including Outpatient Treatment, vocational assistance, or Mental Health therapy.

Average Length of Stay: 3-6 months, depending on the patient’s individualized needs

Supportive Living

Patients receive transitional housing services in conjunction with case management and supportive counseling supports. Programming may include Outpatient Treatment, vocational assistance, or Mental Health therapy.

Average Length of Stay: 6-12 months, depending on the patient’s individualized needs

Medication Assisted Treatment

Opioid dependence is a medical issue that is often treated with Medication Assisted Therapies (MAT’s) in conjunction with counseling and family support. The most commonly used MAT is Suboxone. Methadone has also been used as a MAT for a number of years. Because opioid dependence is a brain disease, using MAT’s that help increase brain functioning becomes an essential part of success with many individuals struggling with opioid dependence. Suboxone, also known as Buprenorphine, blocks the opioid receptors of the brain and essentially “blocks” the effects of the heroin and or other opiates.

Essentially, if an individual attempts to use an opiate to “feel good”, Suboxone prevents this from occurring and therefore discourages the individual from using the opiate. Vivitrol is indicated for use with opioid and alcohol dependent patients. Vivitrol is indicated for long-term abstinence in conjunction with long-term psychosocial support. Vivitrol is administered 1 time a month in an extended release injectable form of Naltrexone. What separates Vivitrol from other MAT’s is that it is not a narcotic, does not have any pleasure producing effects, is not addictive, and has never been associated with a pharmaceutical that has been abused.

Need help navigating the recovery process?

Find help